Regeneron Stock Is Attempting an Upside Breakout

Let's check to see if these gains by the biotech can be sustained.

It's the 'REIT' Time for AGNC, Despite Real Estate Getting Whopped

Here's a trade in AGNC Investment Corp.

GM Seems Stuck in Reverse

General Motors pulls back for a retest of the June/July lows.

Netflix Gets an Upgrade, But I Won't Be Running Up That Hill

The shares have traded sideways the past two months.

The Door to the Market Seems Closed, but I Might 'OPEN' One

This should be a bargain hunter's paradise, but not so much in reality. Here's a stock, however, that stands out.

Traders Race to Catch Bounce as U.K. Chaos Looms in Background

Overnight the U.K saw some of the biggest swings to date in its bond market, as panic set in.

Caterpillar Still Struggles to Find Technical Traction

The charts show that this big name could bounce, but still lacks the ingredients for a sustained climb up.

Biogen and Lilly: How I'm Playing the Alzheimer's Drug Stocks Game

Let's size up the prospects for treatments and the shares.

A Tech Giant and an Obscure Tech Name Have Something in Common: Insider Buying

Significant blocks of stock were bought in both companies, which each have seen their shares decline by more than half so far this year.

As Biogen Surges on Alzheimer Trial Results, Here's How to Play It

BIIB shares have jumped around 50% in early trading activity Wednesday.